Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal of Chemotherapy (Florence, Italy)
|
May 17, 2022
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
Tuğba Başoğlu, Abdullah Sakin, Cihan Erol, et al.
Future Oncology (London, England)
|
October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program
Deniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
Cevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, et al.
Journal of Cancer Research and Therapeutics
|
December 13, 2022
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
Cihan Erol, Mehmet Ali Nahit Sendur, Irem Bilgetekin, et al.
Therapeutic Advances in Medical Oncology
|
March 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
Taha Koray Sahin, Fatih Kemik, Harun Muglu, et al.
International Journal of Cancer
|
October 28, 2025
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group
Salih Tunbekici, Gokhan Sahin, Sercan Ön, et al.
BMC Cancer
|
February 11, 2023
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, et al.
BMC Cancer
|
February 28, 2023
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal of Chemotherapy (Florence, Italy)
|
May 17, 2022
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
Tuğba Başoğlu, Abdullah Sakin, Cihan Erol, et al.
Future Oncology (London, England)
|
October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program
Deniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
Cevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, et al.
Journal of Cancer Research and Therapeutics
|
December 13, 2022
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
Cihan Erol, Mehmet Ali Nahit Sendur, Irem Bilgetekin, et al.
Therapeutic Advances in Medical Oncology
|
March 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study
Taha Koray Sahin, Fatih Kemik, Harun Muglu, et al.
International Journal of Cancer
|
October 28, 2025
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group
Salih Tunbekici, Gokhan Sahin, Sercan Ön, et al.
BMC Cancer
|
February 11, 2023
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, et al.
BMC Cancer
|
February 28, 2023
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, et al.
Page
of 6